Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Breast Cancer Active Surveillance
NCT03491410Phase 3Unknown
- Sponsor
- Centro Hospitalar de Lisboa Ocidental
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Placebo Arm with Aspirin Arm (2 arms). Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Drugs
aspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03491410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491410.